Efficacy of Novel Histone Deacetylase Inhibitor, AR42, in a Mouse Model of Human T-lymphotropic Virus Type 1 Adult T cell Lymphoma

Human T-lymphotropic virus type 1 (HTLV-1) causes a variety of forms of adult T-cell leukemia/lymphoma (ATL), a refractory CD4+/CD25+ T-cell malignancy. Novel approaches to treat ATL patients are required due to the resistance of ATL to conventional chemotherapies. Histone deacetylase inhibitors (HD...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Zimmerman, Bevin, Sargeant, Aaron, Landes, Kristina, Fernandez, Soledad A., Chen, Ching-Shih, Lairmore, Michael D.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: 2011
Konular:
Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC3191315/
https://ncbi.nlm.nih.gov/pubmed/21802726
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.leukres.2011.07.015
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller